Zoetis ZTS
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Zoetis (ZTS) Core Market Data and Business Metrics
Latest Closing Price
$163.5Price-Earnings Ratio
29.89Total Outstanding Shares
447.79 Million SharesDividend
$0.50 Per Share QuarterlySIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
10 Sylvan Way, Parsippany, NJ, 07054
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 3,061,367 Shares | 2.32 | 3/14/2025 | 7,115,165 Shares |
| 3,829,517 Shares | 1.7 | 2/28/2025 | 6,509,170 Shares |
| 3,982,364 Shares | 2.07 | 2/14/2025 | 8,227,125 Shares |
| 2,699,076 Shares | 3.18 | 1/31/2025 | 8,580,316 Shares |
| 2,677,467 Shares | 2.66 | 1/15/2025 | 7,124,062 Shares |
| 2,537,040 Shares | 2.75 | 12/31/2024 | 6,989,508 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $-2.66 Billion |
| Exchange Gains/Losses | $-32 Million |
| Net Cash Flow | $-54 Million |
| Net Cash Flow From Financing Activities, Continuing | $-2.66 Billion |
| Net Cash Flow, Continuing | $-22 Million |
| Net Cash Flow From Investing Activities, Continuing | $-315 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $2.50 Billion |
| Costs And Expenses | $6.12 Billion |
| Basic Earnings Per Share | $5.47 |
| Gross Profit | $6.54 Billion |
| Cost Of Revenue | $2.72 Billion |
| Nonoperating Income/Loss | $19 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $2.38 Billion |
| Other Comprehensive Income/Loss | $-101 Million |
| Comprehensive Income/Loss | $2.40 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $10 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Non-current Assets | $3.73 Billion |
| Other Current Liabilities | $2.54 Billion |
| Noncurrent Liabilities | $6.05 Billion |
| Accounts Payable | $433 Million |
| Intangible Assets | $1.13 Billion |
| Noncurrent Assets | $8.25 Billion |
Historical Dividends
Current dividend: $0.50 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 6, 2025 | Jun 3, 2025 | Apr 21, 2025 | $0.5 | Quarterly |
| Dec 12, 2024 | Mar 4, 2025 | Jan 21, 2025 | $0.5 | Quarterly |
| Oct 10, 2024 | Dec 3, 2024 | Oct 31, 2024 | $0.432 | Quarterly |
| May 22, 2024 | Sep 4, 2024 | Jul 18, 2024 | $0.432 | Quarterly |
| Feb 6, 2024 | Jun 4, 2024 | Apr 19, 2024 | $0.432 | Quarterly |
| Dec 7, 2023 | Mar 1, 2024 | Jan 19, 2024 | $0.432 | Quarterly |